Neuraxis Inc.
Organization details
- Legal name
- Neuraxis Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3845 — Electromedical & Electrotherapeutic Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Carmel
- Headquarters state / province
- Indiana
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NRXS
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001933567
- EIN
- 45-5079684
Board of directors
-
Bradley Mitchell Watkins · DirectorSince 2023
-
Brian Allen Carrico · Director · Chief Executive OfficerSince 2023
-
Christopher Robin Brown · Director · DIRECTOR OF INNOVATIONSince 2023
-
Gil Aharon · DirectorSince 2024
-
Jane Elizabeth Keyser · DirectorSince 2023
-
Kristin A. Ferge · DirectorSince 2024
-
Timothy Robert Henrichs · DirectorSince 2023
Chief executives
Strong · grade B
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 79
10% a year in revenue
20% of the scoring weight is on file. Figures cover December 2022 – December 2025.
Board connections
1 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
Delcath Systems Inc. Same sectorvia Gil Aharon
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,434,253
- 9 purchases by 5 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 8, 2026 | Brian Allen Carrico Director, Officer (Chief Executive Officer) | Open-market purchase | +268 | $4.84 | $1,297 |
| Oct 8, 2026 | Carrico Thomas Joeseph Officer (CRO, CCO, CPO) | Open-market purchase | +328 | $4.84 | $1,588 |
| Oct 8, 2026 | Timothy Robert Henrichs Officer (Chief Financial Officer) | Open-market purchase | +1,937 | $4.84 | $9,375 |
| Aug 24, 2026 | Brian Allen Carrico Director, Officer (Chief Executive Officer) | Grant or award | +199,188 | — | — |
| Aug 24, 2026 | Carrico Thomas Joeseph Officer (CRO, CCO, CPO) | Grant or award | +193,678 | — | — |
| Aug 24, 2026 | Miranda Adrian Officer (CMO, SVP Science & Tech) | Grant or award | +199,106 | — | — |
| Aug 13, 2026 | Kristin A. Ferge Director | Grant or award | +31,134 | $6.28 | $195,522 |
| Aug 13, 2026 | Jane Elizabeth Keyser Director | Grant or award | +26,073 | $6.28 | $163,738 |
| Aug 13, 2026 | Bradley Mitchell Watkins Director | Grant or award | +26,073 | $6.28 | $163,738 |
| Aug 13, 2026 | Gil Aharon Director | Grant or award | +43,930 | $6.28 | $275,880 |
| Jul 29, 2026 | Gil Aharon Director | Grant or award | +2,226 | — | — |
| Jul 29, 2026 | Gil Aharon Director | Grant or award | +40,068 | — | — |
| Apr 28, 2026 | Gil Aharon Director | Grant or award | +12,304 | — | — |
| Apr 28, 2026 | Gil Aharon Director | Grant or award | +221,917 | — | — |
| Apr 1, 2026 | Timothy Robert Henrichs Officer (Chief Financial Officer) | Open-market purchase | +7,593 | $1.96 | $14,882 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Neuraxis Inc.
Who is the CEO of Neuraxis Inc.?
Brian Allen Carrico has been Neuraxis Inc.'s CEO, DIRECTOR since August 2023.
How many directors are on Neuraxis Inc.'s board?
Neuraxis Inc.'s board has 7 directors: Bradley Mitchell Watkins, Brian Allen Carrico, Christopher Robin Brown, Gil Aharon, Jane Elizabeth Keyser, Kristin A. Ferge and Timothy Robert Henrichs.
Are Neuraxis Inc. insiders buying or selling shares?
Over the last 12 months, Neuraxis Inc. insiders bought $1.4 million of shares in 9 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="neuraxis-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.